KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Short-term Investments (2017 - 2025)

Bausch Health Companies (BHC) has disclosed Short-term Investments for 13 consecutive years, with $16.0 million as the latest value for Q4 2025.

  • Quarterly Short-term Investments fell 20.0% to $16.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $16.0 million through Dec 2025, down 20.0% year-over-year, with the annual reading at $16.0 million for FY2025, 20.0% down from the prior year.
  • Short-term Investments hit $16.0 million in Q4 2025 for Bausch Health Companies, down from $32.0 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $1.2 billion in Q2 2022 to a low of $9.0 million in Q2 2023.
  • Historically, Short-term Investments has averaged $334.5 million across 5 years, with a median of $23.0 million in 2025.
  • Biggest five-year swings in Short-term Investments: tumbled 99.26% in 2023 and later surged 211.11% in 2024.
  • Year by year, Short-term Investments stood at $1.2 billion in 2021, then plummeted by 97.78% to $27.0 million in 2022, then tumbled by 44.44% to $15.0 million in 2023, then skyrocketed by 33.33% to $20.0 million in 2024, then fell by 20.0% to $16.0 million in 2025.
  • Business Quant data shows Short-term Investments for BHC at $16.0 million in Q4 2025, $32.0 million in Q3 2025, and $16.0 million in Q2 2025.